These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11305684)

  • 1. Effectiveness of N,N-dimethylglycine in autism and pervasive developmental disorder.
    Kern JK; Miller VS; Cauller PL; Kendall PR; Mehta PJ; Dodd M
    J Child Neurol; 2001 Mar; 16(3):169-73. PubMed ID: 11305684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of porcine secretin in children with autism and pervasive developmental disorder.
    Kern JK; Van Miller S; Evans PA; Trivedi MH
    J Autism Dev Disord; 2002 Jun; 32(3):153-60. PubMed ID: 12108616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder.
    Sandler AD; Sutton KA; DeWeese J; Girardi MA; Sheppard V; Bodfish JW
    N Engl J Med; 1999 Dec; 341(24):1801-6. PubMed ID: 10588965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
    Shea S; Turgay A; Carroll A; Schulz M; Orlik H; Smith I; Dunbar F
    Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial.
    Frye RE; Slattery J; Delhey L; Furgerson B; Strickland T; Tippett M; Sailey A; Wynne R; Rose S; Melnyk S; Jill James S; Sequeira JM; Quadros EV
    Mol Psychiatry; 2018 Feb; 23(2):247-256. PubMed ID: 27752075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
    Research Units on Pediatric Psychopharmacology Autism Network
    Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxytocin-induced increase in N,N-dimethylglycine and time course of changes in oxytocin efficacy for autism social core symptoms.
    Kato Y; Kuwabara H; Okada T; Munesue T; Benner S; Kuroda M; Kojima M; Yassin W; Eriguchi Y; Kameno Y; Murayama C; Nishimura T; Tsuchiya K; Kasai K; Ozaki N; Kosaka H; Yamasue H
    Mol Autism; 2021 Feb; 12(1):15. PubMed ID: 33622389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, placebo-controlled, crossover pilot trial of low dose dimethylglycine in patients with autistic disorder.
    Bolman WM; Richmond JA
    J Autism Dev Disord; 1999 Jun; 29(3):191-4. PubMed ID: 10425581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorder.
    Hollander E; Wasserman S; Swanson EN; Chaplin W; Schapiro ML; Zagursky K; Novotny S
    J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):541-8. PubMed ID: 17069543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavioral effects of Org 2766, a synthetic analog of the adrenocorticotrophic hormone (4-9), in 14 outpatient autistic children.
    Buitelaar JK; van Engeland H; van Ree JM; de Wied D
    J Autism Dev Disord; 1990 Dec; 20(4):467-78. PubMed ID: 2177746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone monotherapy in preschool children with pervasive developmental disorders.
    Masi G; Cosenza A; Mucci M; De Vito G
    J Child Neurol; 2001 Jun; 16(6):395-400. PubMed ID: 11417603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intention-based therapy for autism spectrum disorder: promising results of a wait-list control study in children.
    Weiner RH; Greene RL
    Explore (NY); 2014; 10(1):13-23. PubMed ID: 24439092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Open-label atomoxetine for attention-deficit/ hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders.
    Posey DJ; Wiegand RE; Wilkerson J; Maynard M; Stigler KA; McDougle CJ
    J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):599-610. PubMed ID: 17069548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of neurobehavioral disorders in children supplemented with magnesium-vitamin B6. II. Pervasive developmental disorder-autism.
    Mousain-Bosc M; Roche M; Polge A; Pradal-Prat D; Rapin J; Bali JP
    Magnes Res; 2006 Mar; 19(1):53-62. PubMed ID: 16846101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretin is an ineffective treatment for pervasive developmental disabilities: a review of 15 double-blind randomized controlled trials.
    Sturmey P
    Res Dev Disabil; 2005; 26(1):87-97. PubMed ID: 15590241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy to control behavioral symptoms in children with autism.
    Doyle CA; McDougle CJ
    Expert Opin Pharmacother; 2012 Aug; 13(11):1615-29. PubMed ID: 22550944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of risperidone in children with autism spectrum disorder.
    Chavez B; Chavez-Brown M; Rey JA
    Ann Pharmacother; 2006 May; 40(5):909-16. PubMed ID: 16684811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.
    Akhondzadeh S; Erfani S; Mohammadi MR; Tehrani-Doost M; Amini H; Gudarzi SS; Yasamy MT
    J Clin Pharm Ther; 2004 Apr; 29(2):145-50. PubMed ID: 15068403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological treatment options for autism spectrum disorders in children and adolescents.
    Leskovec TJ; Rowles BM; Findling RL
    Harv Rev Psychiatry; 2008; 16(2):97-112. PubMed ID: 18415882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tetrahydrobiopterin as a treatment for autism spectrum disorders: a double-blind, placebo-controlled trial.
    Klaiman C; Huffman L; Masaki L; Elliott GR
    J Child Adolesc Psychopharmacol; 2013 Jun; 23(5):320-8. PubMed ID: 23782126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.